Note 8 - Debt |
9 Months Ended | |||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2026 | ||||||||||||||||||||||||||||||||||||||||||||||
| Notes to Financial Statements | ||||||||||||||||||||||||||||||||||||||||||||||
| Debt Disclosure [Text Block] |
8) Debt
Long-term debt is comprised of the following (in thousands):
The Company's bank credit agreement matures in February 2028.
At March 31, 2026, and June 30, 2025, the Company had $3.1 million and $1.9 million standby letters of credit outstanding, primarily for insurance purposes and had the ability to borrow $188.0 million and $207.7 million under the Facility. Funds borrowed under the Facility may be used for the repayment of debt, working capital, capital expenditures, acquisitions (so long as certain conditions, including a specified funded debt to EBITDA leverage ratio, are maintained), and other general corporate purposes. The Facility contains customary representations, warranties and restrictive covenants, as well as specific financial covenants which the Company was compliant with as of March 31, 2026 and June 30, 2025.
|
|||||||||||||||||||||||||||||||||||||||||||||